⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer

Official Title: Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer

Study ID: NCT03286920

Study Description

Brief Summary: This clinical trial is designed to be a multi-center prospective observational study which shall compare the effect of different postoperative home nutrition modes on recent nutritional index (weight/BMI) of patients with esophageal cancer and recent outcomes. Different postoperative home nutrition modes adopted in this study includes oral natural diet, oral nutrition supplement and tube feeding.

Detailed Description: STUDY BACKGROUND Esophageal cancer is a common cancer in China and due to its influence on diet intake, patients with esophageal cancer are often combined with nutrition deficiency, which causes relatively high nutrition risk to treatment. Studies conducted by Martin et al showed that the degree of body weight loss in patients with malignancy is related to BMI level and prognosis. The patients with severe body weight loss and low BMI have poor prognosis, especially for patients with esophageal cancer. At present, perioperative nutrition support for patients with esophageal cancer has been recognized and has been recommended as routine in 2017 NCCN guideline. How to implement good home nutrition within one month after patient discharge and recover nutrition index as soon as possible has become a focus for esophageal surgeon. Many clinical trials have already investigated enteral nutrition support approach during anti-cancer treatment period in patients with malignancy. However, only a few clinical trials are good designed. Therefore the investigators hope to via this multi-center prospective observational study to provide evidence for this question. OBJECTIVES: 1. To explore the relationship between postoperative home nutrition support treatment approach and nutritional status of patients with esophageal cancer; 2. To explore the relationship between postoperative home nutrition support treatment approach and recent prognosis in patients with esophageal cancer; 3. To promote the standardized application of postoperative home nutrition support treatment for patients with esophageal cancer.\\ OUTLINE: Included patients shall be divided into three groups according to the treatment plan of all centers, including oral natural diet, oral nutrition supplement and tube feeding. As for patients in oral natural diet group, the patients shall receive oral natural diet. As for patients in oral nutrition supplement group, in addition to oral natural die, the participants shall receive oral enteral supplement providing 750-1500kcal/d. As for patients in tube feeding group, in addition to oral natural die, the participants shall receive tube feeding enteral supplement providing 750-1500kcal/d. All the included patients shall be followed up weekly within 1-3 weeks after discharge via telephone, at Day 30 after discharge and at Day 90 after discharge to assess the effectiveness and safety of different home nutrition supplement approaches. PROJECTED ACCRUAL: A total of 600 patients will be accrued for this study.

Eligibility

Minimum Age:

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

First Affiliated Hospital Bengbu Medical College, Bengbu, Anhui, China

The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China

Beijing Cancer Hospital, Beijing, Beijing, China

China-Japan Friendship Hospital, Beijing, Beijing, China

Chinese PLA General Hospital, Beijing, Beijing, China

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, Chongqing, Chongqing, China

Union hospital of Fujian Medical University, Fuzhou, Fujian, China

Sun Yat-sen University Cancer Hospital, Guangdong, Guangdong, China

Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, Guangdong, China

Hebei Medical University Fourth Hospital, Shijiazhuang, Hebei, China

The Third Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China

Anyang Tumor Hospital, Anyang, Henan, China

Tongji Hospital, Wuhan, Hubei, China

Second Xiangya Hospital of Central South University, Changsha, Hunan, China

First Hospital of Jilin University, Changchun, Jilin, China

Liaoning Tumor Hospital & Institute, Shenyang, Liaoning, China

Qilu Hospital of Shandong University, Jinan, Shandong, China

Shandong Provincial Hospital, Jinan, Shandong, China

Fudan University Cancer Hospital, Shanghai, Shanghai, China

Shanghai Chest Hospital, Shanghai, Shanghai, China

Shanxi Province Cancer Hospital, Taiyuan, Shanxi, China

First People's Hospital of Yunan province, Kunming, Yunan, China

Zhejiang Cancer Hospital, Hanzhou, Zhejiang, China

Contact Details

Name: Keneng Chen, M.D.

Affiliation: Peking University Cancer Hospital & Institute

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: